Cargando…
Early and Long-Term Outcomes of Surgical Treatment of Ebstein’s Anomaly
OBJECTIVE: This study aimed to evaluate Ebstein’s anomaly surgical correction and its early and long-term outcomes. METHODS: A retrospective analysis of 62 consecutive patients who underwent surgical repair of Ebstein’s anomaly in our institution from January 2000 to July 2016. The following long-te...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Cirurgia Cardiovascular
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6852467/ https://www.ncbi.nlm.nih.gov/pubmed/31364344 http://dx.doi.org/10.21470/1678-9741-2018-0333 |
_version_ | 1783469843872219136 |
---|---|
author | da Silva, Guilherme Viotto Rodrigues Miana, Leonardo Augusto Caneo, Luiz Fernando Turquetto, Aída Luiza Ribeiro Tanamati, Carla Penha, Juliano G. Jatene, Fabio B Jatene, Marcelo B |
author_facet | da Silva, Guilherme Viotto Rodrigues Miana, Leonardo Augusto Caneo, Luiz Fernando Turquetto, Aída Luiza Ribeiro Tanamati, Carla Penha, Juliano G. Jatene, Fabio B Jatene, Marcelo B |
author_sort | da Silva, Guilherme Viotto Rodrigues |
collection | PubMed |
description | OBJECTIVE: This study aimed to evaluate Ebstein’s anomaly surgical correction and its early and long-term outcomes. METHODS: A retrospective analysis of 62 consecutive patients who underwent surgical repair of Ebstein’s anomaly in our institution from January 2000 to July 2016. The following long-term outcomes were evaluated: survival, reoperations, tricuspid regurgitation, and postoperative right ventricular dysfunction. RESULTS: Valve repair was performed in 46 (74.2%) patients - 12 of them using the Da Silva cone reconstruction; tricuspid valve replacement was performed in 11 (17.7%) patients; univentricular palliation in one (1.6%) patient; and the one and a half ventricle repair in four (6.5%) patients. The patients’ mean age at the time of surgery was 20.5±14.9 years, and 46.8% of them were male. The mean follow-up time was 8.8±6 years. The 30-day mortality rate was 8.06% and the one and 10-year survival rates were 91.9% both. Eleven (17.7%) of the 62 patients required late reoperation due to tricuspid regurgitation, in an average time of 7.1±4.9 years after the first procedure. CONCLUSION: In our experience, the long-term results of the surgical treatment of Ebstein's anomaly demonstrate an acceptable survival rate and a low incidence of reinterventions. |
format | Online Article Text |
id | pubmed-6852467 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Sociedade Brasileira de Cirurgia Cardiovascular |
record_format | MEDLINE/PubMed |
spelling | pubmed-68524672019-11-15 Early and Long-Term Outcomes of Surgical Treatment of Ebstein’s Anomaly da Silva, Guilherme Viotto Rodrigues Miana, Leonardo Augusto Caneo, Luiz Fernando Turquetto, Aída Luiza Ribeiro Tanamati, Carla Penha, Juliano G. Jatene, Fabio B Jatene, Marcelo B Braz J Cardiovasc Surg Original Article OBJECTIVE: This study aimed to evaluate Ebstein’s anomaly surgical correction and its early and long-term outcomes. METHODS: A retrospective analysis of 62 consecutive patients who underwent surgical repair of Ebstein’s anomaly in our institution from January 2000 to July 2016. The following long-term outcomes were evaluated: survival, reoperations, tricuspid regurgitation, and postoperative right ventricular dysfunction. RESULTS: Valve repair was performed in 46 (74.2%) patients - 12 of them using the Da Silva cone reconstruction; tricuspid valve replacement was performed in 11 (17.7%) patients; univentricular palliation in one (1.6%) patient; and the one and a half ventricle repair in four (6.5%) patients. The patients’ mean age at the time of surgery was 20.5±14.9 years, and 46.8% of them were male. The mean follow-up time was 8.8±6 years. The 30-day mortality rate was 8.06% and the one and 10-year survival rates were 91.9% both. Eleven (17.7%) of the 62 patients required late reoperation due to tricuspid regurgitation, in an average time of 7.1±4.9 years after the first procedure. CONCLUSION: In our experience, the long-term results of the surgical treatment of Ebstein's anomaly demonstrate an acceptable survival rate and a low incidence of reinterventions. Sociedade Brasileira de Cirurgia Cardiovascular 2019 /pmc/articles/PMC6852467/ /pubmed/31364344 http://dx.doi.org/10.21470/1678-9741-2018-0333 Text en http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article da Silva, Guilherme Viotto Rodrigues Miana, Leonardo Augusto Caneo, Luiz Fernando Turquetto, Aída Luiza Ribeiro Tanamati, Carla Penha, Juliano G. Jatene, Fabio B Jatene, Marcelo B Early and Long-Term Outcomes of Surgical Treatment of Ebstein’s Anomaly |
title | Early and Long-Term Outcomes of Surgical Treatment of Ebstein’s
Anomaly |
title_full | Early and Long-Term Outcomes of Surgical Treatment of Ebstein’s
Anomaly |
title_fullStr | Early and Long-Term Outcomes of Surgical Treatment of Ebstein’s
Anomaly |
title_full_unstemmed | Early and Long-Term Outcomes of Surgical Treatment of Ebstein’s
Anomaly |
title_short | Early and Long-Term Outcomes of Surgical Treatment of Ebstein’s
Anomaly |
title_sort | early and long-term outcomes of surgical treatment of ebstein’s
anomaly |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6852467/ https://www.ncbi.nlm.nih.gov/pubmed/31364344 http://dx.doi.org/10.21470/1678-9741-2018-0333 |
work_keys_str_mv | AT dasilvaguilhermeviottorodrigues earlyandlongtermoutcomesofsurgicaltreatmentofebsteinsanomaly AT mianaleonardoaugusto earlyandlongtermoutcomesofsurgicaltreatmentofebsteinsanomaly AT caneoluizfernando earlyandlongtermoutcomesofsurgicaltreatmentofebsteinsanomaly AT turquettoaidaluizaribeiro earlyandlongtermoutcomesofsurgicaltreatmentofebsteinsanomaly AT tanamaticarla earlyandlongtermoutcomesofsurgicaltreatmentofebsteinsanomaly AT penhajulianog earlyandlongtermoutcomesofsurgicaltreatmentofebsteinsanomaly AT jatenefabiob earlyandlongtermoutcomesofsurgicaltreatmentofebsteinsanomaly AT jatenemarcelob earlyandlongtermoutcomesofsurgicaltreatmentofebsteinsanomaly |